Wogonin has been demonstrated to decrease the expression of HK2, LDHA, and GLUT1, hence reducing glycolysis and cell proliferation in ovarian and liver cancer cells (Zhao et al., 2018a). The gene discussed is LDHA; the disease is liver cancer.